[Image courtesy of The iQ Group Global]
The iQ Group Global announced today that it has inked a collaboration with Harvard’s Wyss Institute to develop a printable point-of-care SARS-CoV-2 antibody test with real-time results.
Life Science Biosensor Diagnostics, the iQ Group’s development company, has been working on the Australian-invented Biosensor Platform, a printable organic thin-film transistor “strip” that has the potential to provide a variety of medical tests — and even potentially replace blood glucose finger stick tests for diabetics. The Wyss Institute for Biologically Inspired Engineering at Harvard University has meanwhile created a special coating that can detect IgM and/or IgG antibodies.
Get the full story on our sister site Medical Design & Outsourcing.